Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
NovoCure Limited (NVCR) had Weighted-Average Shares Outstanding (Diluted) of 107.83M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$605.22M |
|
$-168.63M |
|
$137.18M |
|
$468.04M |
|
$775.72M |
|
$-170.50M |
|
$39.33M |
|
$-131.16M |
|
$-131.16M |
|
$-168.63M |
|
$-168.63M |
|
$-168.63M |
|
$-168.63M |
|
$-170.50M |
|
$-184.91M |
|
107.83M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
107.83M |
$-1.56 |
|
$-1.56 |
|
| Balance Sheet Financials | |
$1.11B |
|
$92.47M |
|
$134.21M |
|
$1.24B |
|
$756.38M |
|
$97.30M |
|
$124.23M |
|
$880.61M |
|
$360.18M |
|
$360.18M |
|
$360.18M |
|
108.52M |
|
| Cash Flow Statement Financials | |
$-26.37M |
|
$-140.24M |
|
$90.31M |
|
$242.56M |
|
$166.09M |
|
$-76.47M |
|
$160.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.46 |
|
-- |
|
-- |
|
0.21 |
|
1.82 |
|
77.33% |
|
-28.17% |
|
-28.17% |
|
-30.55% |
|
-21.67% |
|
-27.86% |
|
$-69.22M |
|
-- |
|
-- |
|
-- |
|
0.49 |
|
3.91 |
|
5.54 |
|
65.91 |
|
-46.82% |
|
-46.82% |
|
-13.59% |
|
-36.86% |
|
$3.32 |
|
$-0.64 |
|
$-0.24 |
|